Gujarat Kidney Shares to List Dec 30: Buy, Sell, or Hold?

• Gujarat Kidney and Super Speciality shares may list on stock exchanges on December 30, following an IPO subscribed 5.21 times.
• The IPO, worth 251 crore rupees with a price band of 108-114 rupees, saw shares trading at a premium in the grey market.
• Expert Ravi Singh highlights India's hospital industry's structural growth, projected to reach 8,200 crore rupees by FY2026, driven by demand and government initiatives.
• Gujarat Kidney is poised to benefit from increasing healthcare demand, expanding services, and investing in technology, focusing on affordable care.
• IPO proceeds will fund acquisitions of Parekhs Hospitals and Ashwini Medical Centre, plus a new hospital in Vadodara; investors are advised to hold for long-term gains.

Why It Matters: Hold Gujarat Kidney shares long-term for potential gains, benefiting from India's growing healthcare sector.